Science

Jul 22, 2025, 15:31

Myeloma Paper of the Day, July 22nd, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Viewpoint piece makes evidence-based arguments for use of primary prophylaxis as a safer and simpler approach compared to preemptive IgG-guided immunoglobulin replacement therapy in patients getting bispecific antibodies.”

Title: IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma, regardless of IgG levels

Authors: Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J McCaughan, Nikhil M Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje

You can read the Full Article in Blood Advances.

Myeloma Paper of the Day, July 22nd, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Benjamin R. Puliafito Bhausaheb Bagal cancer Diana D. Cirstea Georgia J McCaughan Gurbakhash Kaur IVIG Kai Rejeski Meera Mohan Myeloma Myeloma Paper of the Day Nikhil M Kumar Nikita Mehra Noopur S. Raje OncoDaily Oncology Rahul Banerjee Robert Orlowski Shonali Midha

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment

ASCO 2026 Presidential Theme: Dr. Eric Small’s Vision to Translate Science Into Global Cancer Impact

Ravi B. Parikh: Is Accelerated FDA Approval 23 Times Stronger than the Traditional?

Habib Nehmé: The U.S. Market Remains Elekta’s Most Strategic and Significant One

Mohamad Mohty: DREAMM-7 Marks a Step Forward in Relapsed Myeloma